Nicotine Polacrilex Lozenge
Product Images NDC 71335-2730

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 71335-2730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (713352730 E Label)

This text provides important usage instructions for a nicotine lozenge product for smoking cessation. It includes guidelines on dosage based on the time of the first cigarette after waking up and a structured 12-week schedule for the gradual reduction of nicotine intake. It also highlights the need to consult a doctor if under 18 years old and emphasizes reading the enclosed User's Guide for detailed directions and essential information.*

FDA Label Image

Wallet Card Image 1 (Image 01)

Not available.*

FDA Label Image

Wallet Card Image 2 (Image 02)

This text seems to be a list of emergency contact numbers for organizations related to health issues such as lung, cancer, and heart diseases. It also suggests seeking support from a "Quitting Buddy" or a friend who has successfully quit a habit. This information could be part of a wallet card for quick access to help and support during tough times.*

FDA Label Image

Smoke Free Habits Logo (Image 03)

Free & Personalized Support Plan available at IS_IokeFreehabits.com. This plan offers tailored and no-cost assistance to help users develop positive habits.*

FDA Label Image

Upc Example (Image 04)

FDA Label Image

Reminder Stickers (Image 05)

This text provides a schedule for reminders to be placed on your calendar for a step-by-step approach to quitting smoking using lozenges. It includes information on the frequency of lozenge intake at different stages of the process, such as every 1 to 2 hours or 2 to 4 hours. Additionally, it outlines specific milestones at week 1 (quit date), week 7, week 10, and 12 weeks after the quit date to help guide ex-smokers through the process.*

FDA Label Image

Label (Lbl713352730)

The text provides information on a package insert for a nicotine lozenge designed to aid in smoking cessation. It includes details on the active ingredient, directions for use, warnings regarding potential side effects, dosage recommendations, and storage information. The product is designed to help reduce withdrawal symptoms associated with quitting smoking. It is important to follow the instructions carefully and consult a doctor if you have specific health conditions. The lozenge is mint-flavored and should be used as directed for optimal results.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.